Hakutulokset - Jeffrey Perl

Tarkenna hakua
  1. 1
    Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral?

    Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral? Tekijä Edwina A. Brown, Jeffrey Perl

    Julkaistu 2020
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Center-Centered in a Patient-Centered World?

    Center-Centered in a Patient-Centered World? Tekijä Thyago Proença de Moraes, Jeffrey Perl

    Julkaistu 2016
    Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’

    Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’ Tekijä Jeffrey Perl, Mark L. Unruh, Christopher T. Chan

    Julkaistu 2006
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Practical Considerations When Prescribing Icodextrin: A Narrative Review

    Practical Considerations When Prescribing Icodextrin: A Narrative Review Tekijä Samuel A. Silver, Ziv Harel, Jeffrey Perl

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

    The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? Tekijä Jeffrey Perl, Sharon J. Nessim, Joanne M. Bargman

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Peritoneal Dialysis–Associated Peritonitis: Suggestions for Management and Mistakes to Avoid

    Peritoneal Dialysis–Associated Peritonitis: Suggestions for Management and Mistakes to Avoid Tekijä Muthana Al Sahlawi, Joanne M. Bargman, Jeffrey Perl

    Julkaistu 2020
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients

    Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients Tekijä Jeffrey Perl, Kit Huckvale, Michelle Chellar, Biju John, Simon Davies

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Peritoneal Dialysis in Critically Ill Patients

    Peritoneal Dialysis in Critically Ill Patients Tekijä Muthana Al Sahlawi, Daniela Ponce, David M. Charytan, Brett Cullis, Jeffrey Perl

    Julkaistu 2022
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    The Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada

    The Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada Tekijä Louis‐Charles Desbiens, Karthik Tennankore, Jeffrey Perl, Christopher T. Chan, Annie‐Claire Nadeau‐Fredette

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to You by the COVID-19 Pandemic

    Peritoneal Dialysis for Acute Kidney Injury Treatment in the United States: Brought to You by the COVID-19 Pandemic Tekijä Vesh Srivatana, Vikram Aggarwal, Fredric O. Finkelstein, Mihran V. Naljayan, John H. Crabtree, Jeffrey Perl

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    The risk of peritonitis after an exit site infection: a time-matched, case–control study

    The risk of peritonitis after an exit site infection: a time-matched, case–control study Tekijä Alissa Lloyd, Navdeep Tangri, Leigh Anne Shafer, Claudio Rigatto, Jeffrey Perl, Paul Komenda, Manish M. Sood

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Impact of Dialysis Modality on Survival after Kidney Transplant Failure

    Impact of Dialysis Modality on Survival after Kidney Transplant Failure Tekijä Jeffrey Perl, Omar Hasan, Joanne M. Bargman, Depeng Jiang, Yingbo Na, John S. Gill, Sarbjit V. Jassal

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

    The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis Tekijä Ziv Harel, Cameron Gilbert, Ron Wald, Chaim M. Bell, Jeffrey Perl, David N. Juurlink, Joseph Beyene, Prakesh S. Shah

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD

    Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD Tekijä Ziv Harel, Michelle Sholzberg, Prakesh S. Shah, Katerina Pavenski, Shai Har-El, Ron Wald, Chaim M. Bell, Jeffrey Perl

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis

    Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis Tekijä Jenny I. Shen, Lucia Chen, Sitaram Vangala, Lynn Leng, Anuja Shah, Anjali Saxena, Jeffrey Perl, Keith C. Norris

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Changes in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada

    Changes in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada Tekijä Jeffrey Perl, Ron Wald, Joanne M. Bargman, Yingbo Na, Sarbjit V. Jassal, Arsh K. Jain, Louise Moist, Sharon J. Nessim

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study

    Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study Tekijä Jeffrey Perl, J. Zhang, Brenda W. Gillespie, Björn Wíkström, Joan Fort, Takeshi Hasegawa, Douglas S. Fuller, R. Pisoni, Bruce Robinson, Francesca Tentori

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival

    Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival Tekijä Jeffrey Perl, Ron Wald, Philip A. McFarlane, Joanne M. Bargman, Edward F. Vonesh, Yingbo Na, Sarbjit V. Jassal, Louise Moist

    Julkaistu 2011
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    A Palliative Approach to Dialysis Care

    A Palliative Approach to Dialysis Care Tekijä Vanessa Grubbs, Alvin H. Moss, Lewis M. Cohen, Michael J. Fischer, Michael J. Germain, Sarbjit V. Jassal, Jeffrey Perl, Daniel E. Weiner, Rajnish Mehrotra

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    The Risk of Major Hemorrhage with CKD

    The Risk of Major Hemorrhage with CKD Tekijä Amber O. Molnar, Sarah E. Bota, Amit X. Garg, Ziv Harel, Ngan N. Lam, Eric McArthur, Gihad Nesrallah, Jeffrey Perl, Manish M. Sood

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: